187 related articles for article (PubMed ID: 23246850)
1. To biopsy or not to biopsy: minimizing the risk of prostate needle biopsy.
Kibel AS
J Urol; 2013 Mar; 189(3):796-7. PubMed ID: 23246850
[No Abstract] [Full Text] [Related]
2. Re: To biopsy or not to biopsy: minimizing the risk of prostate needle biopsy: A. S. Kibel J Urol 2013; 189: 796-797.
Horan AH
J Urol; 2013 Sep; 190(3):1139. PubMed ID: 23583228
[No Abstract] [Full Text] [Related]
3. Reply by author.
J Urol; 2013 Sep; 190(3):1140. PubMed ID: 23770372
[No Abstract] [Full Text] [Related]
4. Re: Is repeat prostate biopsy associated with a greater risk of hospitalization? Data from SEER-Medicare: S. Loeb, H. B. Carter, S. I. Berndt, W. Ricker and E. M. Schaeffer J Urol 2013; 189: 867-870.
Singh I; Gautam L
J Urol; 2013 Oct; 190(4):1439-40. PubMed ID: 23886882
[No Abstract] [Full Text] [Related]
5. Reply by authors.
J Urol; 2013 Oct; 190(4):1440. PubMed ID: 23886879
[No Abstract] [Full Text] [Related]
6. The number of cores taken in patients diagnosed with a single microfocus at initial biopsy is a major predictor of insignificant prostate cancer.
Villa L; Capitanio U; Briganti A; Abdollah F; Suardi N; Salonia A; Gallina A; Freschi M; Russo A; Castiglione F; Bianchi M; Rigatti P; Montorsi F; Scattoni V
J Urol; 2013 Mar; 189(3):854-9. PubMed ID: 23022004
[TBL] [Abstract][Full Text] [Related]
7. Commentary on "Is repeat prostate biopsy associated with a greater risk of hospitalization? Data from SEER-Medicare." Loeb S, Carter HB, Berndt SI, Ricker W, Schaeffer EM, Department of Urology, New York University, New York, NY. J Urol 2013; 189(3):867-70. [Epub 2012 Oct 9]. doi: 10.1016/j.juro.2012.10.005.
Eggener S
Urol Oncol; 2014 Aug; 32(6):935-6. PubMed ID: 25087672
[TBL] [Abstract][Full Text] [Related]
8. Is repeat prostate biopsy associated with a greater risk of hospitalization? Data from SEER-Medicare.
Loeb S; Carter HB; Berndt SI; Ricker W; Schaeffer EM
J Urol; 2013 Mar; 189(3):867-70. PubMed ID: 23063634
[TBL] [Abstract][Full Text] [Related]
9. Prostate cancer polar localization on core biopsy predicts pathologic stage.
Hensley PJ; Bailey LR; Purdom MS; Davenport DL; Strup SE
Can J Urol; 2016 Dec; 23(6):8551-8556. PubMed ID: 27995850
[TBL] [Abstract][Full Text] [Related]
10. Words of wisdom: re: transperineal magnetic resonance image targeted prostate biopsy versus transperineal template prostate biopsy in the detection of clinically significant prostate cancer.
Ravery V
Eur Urol; 2013 Aug; 64(2):337. PubMed ID: 23830225
[No Abstract] [Full Text] [Related]
11. [The pathologist's role: to diagnose prostatic cancer and determine prognosis].
Egevad L
Lakartidningen; 2012 Feb 22-28; 109(8):403-6. PubMed ID: 22509665
[No Abstract] [Full Text] [Related]
12. Editorial comment.
Labanaris AP
J Urol; 2013 Mar; 189(3):866. PubMed ID: 23261235
[No Abstract] [Full Text] [Related]
13. Gleason grading of prostate cancer in needle biopsies vs. radical prostatectomy specimens.
Vidal-Jimenez A
Anal Quant Cytol Histol; 2006 Dec; 28(6):340-1. PubMed ID: 17225300
[No Abstract] [Full Text] [Related]
14. Re: Transperineal template-guided saturation biopsy using a modified technique: outcome of 270 cases requiring repeat prostate biopsy.
Taneja SS
J Urol; 2013 Oct; 190(4):1245-6. PubMed ID: 24029308
[No Abstract] [Full Text] [Related]
15. Extent of cancer of less than 50% in any prostate needle biopsy core: how many millimeters are there?
Montironi R; Scarpelli M; Mazzucchelli R; Cheng L; Lopez-Beltran A; Montorsi F
Eur Urol; 2012 Apr; 61(4):751-6. PubMed ID: 22239991
[No Abstract] [Full Text] [Related]
16. Value of transition zone biopsy in active surveillance of prostate cancer.
Wang CC; Carter HB; Epstein JI
J Urol; 2014 Jun; 191(6):1755-9. PubMed ID: 24316092
[TBL] [Abstract][Full Text] [Related]
17. Is an extended 20-core prostate biopsy protocol more efficient than the standard 12-core? A randomized multicenter trial.
Irani J; Blanchet P; Salomon L; Coloby P; Hubert J; Malavaud B; Mottet N
J Urol; 2013 Jul; 190(1):77-83. PubMed ID: 23313205
[TBL] [Abstract][Full Text] [Related]
18. Outcome of Gleason 3 + 5 = 8 Prostate Cancer Diagnosed on Needle Biopsy: Prognostic Comparison with Gleason 4 + 4 = 8.
Harding-Jackson N; Kryvenko ON; Whittington EE; Eastwood DC; Tjionas GA; Jorda M; Iczkowski KA
J Urol; 2016 Oct; 196(4):1076-81. PubMed ID: 27265220
[TBL] [Abstract][Full Text] [Related]
19. Transrectal ultrasonography-guided biopsy does not reliably identify dominant cancer location in men with low-risk prostate cancer.
Washington SL; Bonham M; Whitson JM; Cowan JE; Carroll PR
BJU Int; 2012 Jul; 110(1):50-5. PubMed ID: 22077660
[TBL] [Abstract][Full Text] [Related]
20. The utility of artificial intelligence in the assessment of prostate pathology.
Egevad L; Ström P; Kartasalo K; Olsson H; Samaratunga H; Delahunt B; Eklund M
Histopathology; 2020 May; 76(6):790-792. PubMed ID: 32402150
[No Abstract] [Full Text] [Related]
[Next] [New Search]